FibroGen Inc (FGEN)
0.3148
-0.01
(-2.33%)
USD |
NASDAQ |
Nov 05, 11:37
FibroGen Price: 0.3148 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 0.32 | 0.3299 | 0.318 | 0.3223 | 473621.0 |
Nov 01, 2024 | 0.3014 | 0.3352 | 0.3011 | 0.3189 | 769317.0 |
Oct 31, 2024 | 0.3122 | 0.3215 | 0.29 | 0.3014 | 1.208M |
Oct 30, 2024 | 0.3062 | 0.3252 | 0.303 | 0.3178 | 1.161M |
Oct 29, 2024 | 0.31 | 0.3103 | 0.298 | 0.3062 | 1.357M |
Oct 28, 2024 | 0.31 | 0.33 | 0.2957 | 0.2988 | 2.226M |
Oct 25, 2024 | 0.32 | 0.34 | 0.304 | 0.308 | 2.752M |
Oct 24, 2024 | 0.33 | 0.3364 | 0.3186 | 0.32 | 1.617M |
Oct 23, 2024 | 0.3454 | 0.3622 | 0.319 | 0.32 | 1.215M |
Oct 22, 2024 | 0.367 | 0.381 | 0.3503 | 0.3503 | 1.206M |
Oct 21, 2024 | 0.40 | 0.40 | 0.355 | 0.3745 | 1.171M |
Oct 18, 2024 | 0.395 | 0.4017 | 0.375 | 0.3915 | 862911.0 |
Oct 17, 2024 | 0.38 | 0.395 | 0.3669 | 0.395 | 2.716M |
Oct 16, 2024 | 0.3544 | 0.3757 | 0.3544 | 0.3757 | 429791.0 |
Oct 15, 2024 | 0.35 | 0.38 | 0.3433 | 0.3544 | 1.369M |
Oct 14, 2024 | 0.3592 | 0.3622 | 0.336 | 0.3431 | 866342.0 |
Oct 11, 2024 | 0.337 | 0.3573 | 0.3368 | 0.3573 | 830678.0 |
Oct 10, 2024 | 0.3277 | 0.3429 | 0.3117 | 0.337 | 1.216M |
Oct 09, 2024 | 0.3382 | 0.3382 | 0.3011 | 0.3277 | 1.415M |
Oct 08, 2024 | 0.346 | 0.346 | 0.3099 | 0.3284 | 2.550M |
Oct 07, 2024 | 0.3812 | 0.39 | 0.335 | 0.3426 | 2.171M |
Oct 04, 2024 | 0.38 | 0.3988 | 0.3641 | 0.3667 | 915203.0 |
Oct 03, 2024 | 0.3978 | 0.4048 | 0.3861 | 0.3989 | 410413.0 |
Oct 02, 2024 | 0.3877 | 0.4004 | 0.37 | 0.3999 | 582908.0 |
Oct 01, 2024 | 0.393 | 0.412 | 0.3782 | 0.392 | 407936.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.2988
Minimum
Oct 28 2024
55.72
Maximum
Feb 12 2021
18.80
Average
14.37
Median
Jan 04 2022
Price Benchmarks
Merck & Co Inc | 101.38 |
Biomarin Pharmaceutical Inc | 65.84 |
Arbutus Biopharma Corp | 3.865 |
GlycoMimetics Inc | 0.3931 |
Cidara Therapeutics Inc | 13.18 |
Price Related Metrics
PS Ratio | 0.1791 |
Earnings Yield | -543.2% |
Market Cap | 31.61M |